Express Scripts, the largest pharmacy benefits manager in the U.S., says it's got a plan to fight drug price increases: Refuse to pay.
Jim Cramer saw biotech has now become a pariah of pain for stocks everywhere. Can the market infection ever be cured?
HEDGE FUND MANAGER BILL ACKMAN SAYS HILARY CLINTON VIEW ON PHARMACEUTICAL REGULATION HAS NOT CHANGED VIEW OF SECTOR.
U.S. biotech shares extended their downward spiral on Tuesday as concerns about drug pricing continued to plague the sector.
From marijuana to same-sex marriage, the GOP is striking out with millennials on issues that are important to young people, says Jack Hunter.
Morgan Stanley analyzed the drug pricing issue and found which companies are the best and worst positioned in a note sent to clients on Thursday.
Despite the retirement crisis, GOP candidates are avoiding the issue on the campaign trail, Bailey Childers says. Here's why.
Kris Balderston, senior vice president, senior partner & GM at Fleishman-Hillard, explains why the 2016 U.S. presidential race is shaping up to be the most interesting yet.
Republican branding problems and stances on social issues could keep this group from turning out.
If Donald Trump did build an immigration wall, it would cost billions. Would it be worth the money?
The billionaire tech impresario said in a tweet he may run for the House's top spot.
As outrage has cooled so has the tough talk from the bevy of hopefuls looking to win the 2016 race.